Clinical Oncology
Volume 21, Issue 8 , Pages 610-616, October 2009

Effect of the UK Postcode Lottery on Survival of Patients with Metastatic Renal Cancer: an Audit of Outcomes in Patients with Metastatic Renal Cancer Suitable for Treatment with Tyrosine Kinase Inhibitors

  • N. James

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • ,
  • J. Pascoe

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Corresponding Author InformationAuthor for correspondence: N. James, CRUK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Tel: +44-121-414-4097.
    • ,
  • A. Zachariah

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • D. Ray

      Affiliations

    • Quality Outcomes Research Unit, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • A. Oldroyd

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • H. Parry

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • H. Benghiat

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • M. Karina

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • S. Collins

      Affiliations

    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • ,
  • E. Porfiri

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

Received 19 October 2008; received in revised form 13 May 2009; accepted 23 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(09)00189-7

doi:10.1016/j.clon.2009.06.007

Clinical Oncology
Volume 21, Issue 8 , Pages 610-616, October 2009

Article Tools

* Image Usage & Resolution